Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 1;18(3):454-467.
doi: 10.1093/pm/pnw140.

Survey of Primary Care and Mental Health Prescribers' Perspectives on Reducing Opioid and Benzodiazepine Co-Prescribing Among Veterans

Affiliations

Survey of Primary Care and Mental Health Prescribers' Perspectives on Reducing Opioid and Benzodiazepine Co-Prescribing Among Veterans

Eric J Hawkins et al. Pain Med. .

Abstract

Background: Due to the involvement of opioids and benzodiazepines in rising pharmaceutical overdoses, a reduction in coprescribing of these medications is a national priority, particularly among patients with substance use disorders and other high-risk conditions. However, little is known about primary care (PC) and mental health (MH) prescribers' perspectives on these medications and efforts being implemented to reduce coprescribing.

Design: An anonymous survey.

Setting: One multisite VA health care system.

Subjects: Participants were 55 PC and 31 MH prescribers.

Methods: Survey development was guided by the Promoting Action on Research Implementation in Health Services (PARIHS) conceptual framework. PC and MH prescribers of opioids or benzodiazepines were invited to complete an anonymous electronic survey. Responses were collapsed to highlight agreement, disagreement, and neutrality and summarized with means and percentages.

Results: Over 80% of both prescriber groups reported concern about concurrent use and > 75% strongly agreed with clinical practice guidelines (CPG) that recommend caution in coprescribing among patients with high-risk conditions. More than 40% of both prescriber groups indicated that coprescribing continues because of beliefs that patients appear stable without adverse events and tapering/discontinuation is too difficult. Over 70% of prescribers rated strategies for addressing patients who refuse to discontinue, more time with patients, and identification of high-risk patients as helpful in reducing coprescribing.

Conclusion: Despite strong agreement with CPGs, prescribers reported several barriers that contribute to coprescribing of opioids and benzodiazepines and challenge their ability to taper these medications. Multiple interventions are likely needed to reduce opioid and benzodiazepine coprescribing.

Keywords: Attitudes; Beliefs; Chronic Pain; Concurrent Opioid and Benzodiazepine Use; High-Risk Conditions; Mental Health; Primary Care.

PubMed Disclaimer

Conflict of interest statement

Disclosures/Conflicts of Interest

The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or University of Washington.

Figures

Figure 1a.
Figure 1a.
Typical functioning and quality of life outcome for patients prescribed opioids and benzodiazepines concurrently
Figure 1b.
Figure 1b.
Typical change in patient functioning when long-term opioid or benzodiazepine therapy is discontinued

Similar articles

Cited by

References

    1. Park TW, et al., Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ, 2015. 350: p. h2698. - PMC - PubMed
    1. Jones CM, Mack KA, and Paulozzi LJ, Pharmaceutical overdose deaths, United States, 2010. JAMA, 2013. 309(7): p. 657–9. - PubMed
    1. Spitzer C, et al., Association of airflow limitation with trauma exposure and post-traumatic stress disorder. Eur Respir J, 2011. 37(5): p. 1068–75. - PubMed
    1. Williams SG, et al., Sleep disorders in combat-related PTSD. Sleep Breath, 2014. - PubMed
    1. Sehgal N, Colson J, and Smith HS, Chronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy. Expert Rev Neurother, 2013. 13(11): p. 1201–20. - PubMed

MeSH terms